Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 3
2004 2
2005 6
2006 7
2007 15
2008 18
2009 25
2010 34
2011 23
2012 23
2013 13
2014 17
2015 12
2016 13
2017 15
2018 22
2019 18
2020 15
2021 21
2022 16
2023 22
2024 14
2025 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

308 results

Results by year

Filters applied: . Clear all
Page 1
Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019.
Giri VN, Knudsen KE, Kelly WK, Cheng HH, Cooney KA, Cookson MS, Dahut W, Weissman S, Soule HR, Petrylak DP, Dicker AP, AlDubayan SH, Toland AE, Pritchard CC, Pettaway CA, Daly MB, Mohler JL, Parsons JK, Carroll PR, Pilarski R, Blanco A, Woodson A, Rahm A, Taplin ME, Polascik TJ, Helfand BT, Hyatt C, Morgans AK, Feng F, Mullane M, Powers J, Concepcion R, Lin DW, Wender R, Mark JR, Costello A, Burnett AL, Sartor O, Isaacs WB, Xu J, Weitzel J, Andriole GL, Beltran H, Briganti A, Byrne L, Calvaresi A, Chandrasekar T, Chen DYT, Den RB, Dobi A, Crawford ED, Eastham J, Eggener S, Freedman ML, Garnick M, Gomella PT, Handley N, Hurwitz MD, Izes J, Karnes RJ, Lallas C, Languino L, Loeb S, Lopez AM, Loughlin KR, Lu-Yao G, Malkowicz SB, Mann M, Mille P, Miner MM, Morgan T, Moreno J, Mucci L, Myers RE, Nielsen SM, O'Neil B, Pinover W, Pinto P, Poage W, Raj GV, Rebbeck TR, Ryan C, Sandler H, Schiewer M, Scott EMD, Szymaniak B, Tester W, Trabulsi EJ, Vapiwala N, Yu EY, Zeigler-Johnson C, Gomella LG. Giri VN, et al. Among authors: polascik tj. J Clin Oncol. 2020 Aug 20;38(24):2798-2811. doi: 10.1200/JCO.20.00046. Epub 2020 Jun 9. J Clin Oncol. 2020. PMID: 32516092 Free PMC article.
Editorial Comment.
Arcot R, Polascik TJ. Arcot R, et al. Among authors: polascik tj. J Urol. 2021 Nov;206(5):1182-1183. doi: 10.1097/JU.0000000000001934.01. Epub 2021 Aug 11. J Urol. 2021. PMID: 34379453 No abstract available.
Reply by Authors.
Taich L, Zhao H, Stock SR, Howard LE, De Hoedt AM, Terris MK, Amling CL, Kane CJ, Cooperberg MR, Aronson WJ, Klaassen Z, Polascik TJ, Vidal AC, Freedland SJ. Taich L, et al. Among authors: polascik tj. Urol Pract. 2022 Sep;9(5):413. doi: 10.1097/UPJ.0000000000000316.03. Epub 2022 Aug 22. Urol Pract. 2022. PMID: 37145765 No abstract available.
AUTHOR REPLY.
Morris KE, Kotamarti S, Polascik TJ, Moul JW. Morris KE, et al. Among authors: polascik tj. Urology. 2023 May;175:149-150. doi: 10.1016/j.urology.2022.12.060. Urology. 2023. PMID: 37257987 No abstract available.
Editorial Comment.
Polascik TJ. Polascik TJ. J Urol. 2021 Aug;206(2):336. doi: 10.1097/JU.0000000000001771.01. Epub 2021 May 7. J Urol. 2021. PMID: 33960823 No abstract available.
Editorial Comment.
Polascik TJ. Polascik TJ. J Urol. 2019 Dec;202(6):1164-1165. doi: 10.1097/01.JU.0000581800.01651.5c. Epub 2019 Aug 30. J Urol. 2019. PMID: 31469606 No abstract available.
A Description and Safety Overview of Irreversible Electroporation for Prostate Tissue Ablation in Intermediate-Risk Prostate Cancer Patients: Preliminary Results from the PRESERVE Trial.
George AK, Miocinovic R, Patel AR, Lomas DJ, Correa AF, Chen DYT, Rastinehad AR, Schwartz MJ, Uchio EM, Sidana A, Helfand BT, Gahan JC, Yu A, Vourganti S, Barqawi AB, Brisbane WG, Wysock JS, Polascik TJ, McClure TD, Coleman JA. George AK, et al. Among authors: polascik tj. Cancers (Basel). 2024 Jun 8;16(12):2178. doi: 10.3390/cancers16122178. Cancers (Basel). 2024. PMID: 38927884 Free PMC article.
Molecular Mechanisms of Castrate-Resistant Prostate Cancer.
Kotamarti S, Armstrong AJ, Polascik TJ, Moul JW. Kotamarti S, et al. Among authors: polascik tj. Urol Clin North Am. 2022 Nov;49(4):615-626. doi: 10.1016/j.ucl.2022.07.005. Epub 2022 Oct 7. Urol Clin North Am. 2022. PMID: 36309418 Review.
Editorial Comment.
Polascik TJ, Tay KJ. Polascik TJ, et al. J Urol. 2016 Sep;196(3):889. doi: 10.1016/j.juro.2016.02.3001. Epub 2016 Jun 1. J Urol. 2016. PMID: 27260991 No abstract available.
Surveillance after prostate focal therapy.
Tay KJ, Amin MB, Ghai S, Jimenez RE, Kench JG, Klotz L, Montironi R, Muto S, Rastinehad AR, Turkbey B, Villers A, Polascik TJ. Tay KJ, et al. Among authors: polascik tj. World J Urol. 2019 Mar;37(3):397-407. doi: 10.1007/s00345-018-2363-y. Epub 2018 Jun 9. World J Urol. 2019. PMID: 29948045 Review.
308 results